Oddity Tech Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ODD research report →
Range $8 – $20
Price Chart
About the company
Operating globally, Oddity Tech Ltd. and its affiliated companies function as a consumer technology enterprise. It delivers beauty and wellness merchandise, leveraging its proprietary PowerMatch technology.
- CEO
- Oran Holtzman
- IPO
- 2023
- Employees
- 658
- HQ
- Jaffa, IL
Get TickerSpark's AI analysis on ODD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $776.30M
- P/E
- 59.22
- Fwd P/E
- 25.64
- PEG
- -0.67
- P/S
- 1.15
- P/B
- 2.45
- EV/EBITDA
- 62.09
- Div Yield
- 0.00%
- Gross Margin
- 69.10%
- Op Margin
- -2.22%
- Net Margin
- 1.27%
- ROE
- 2.88%
- ROIC
- -0.80%
Latest fiscal year · YoY change
- Revenue
- $809.84M+25.2%
- Gross Profit
- $588.71M+25.7%
- Op Income
- $118.77M
- Net Income
- $110.75M+9.1%
- EPS
- $1.95+9.6%
- OCF Growth
- -36.4%
- FCF Growth
- -35.5%
- 52W High
- $46.45
- 52W Low
- $9.25
- 50D MA
- $19.71
- 200D MA
- $16.43
- Beta
- 2.15
- RSI (14)
- 30
- Avg Volume
- 1.16M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
ODDITY beat Q3 expectations, stabilized trends sequentially, and raised full-year guidance, but IL MAKIAGE remains pressured by an unresolved ad-platform algorithm issue.· November 11, 2026
- Q3 revenue was $145 million, down 2% year over year, but better than the company’s prior view for about a 5% decline.
- Gross margin was 67.4% versus 71.6% a year ago; adjusted EBITDA was $22 million, above guidance of $18 million to $20 million.
- SpoiledChild was a bright spot, growing strong double digits and tracking to at least 35% growth for the year, approaching $350 million in revenue.
- METHODIQ is scaling quickly and management said it is on track to beat SpoiledChild’s first-year revenue performance.
- Management raised 2026 guidance and continued to frame 2027 as a return-to-growth year, but IL MAKIAGE is still working through ad-partner dislocation and inventory issues.
ODDITY reported third-quarter net revenue of $145 million, down 2% year over year, versus prior guidance for approximately a 5% decline. Gross margin was 67.4%, compared with 71.6% in the prior year. Adjusted EBITDA was $22 million, above the prior outlook of $18 million to $20 million, and adjusted diluted EPS was $0.37 versus $0.40 a year ago. Free cash flow was $10 million in the quarter, and inventory ended at $158 million. For the full year, management raised net revenue guidance to a decline of approximately 18.5% and raised adjusted EBITDA guidance to $32 million to $34 million.
Oran Holtzman said the company is stabilizing the business and positioning for growth in 2027, with a focus on launching new products and categories across all brands. He emphasized that SpoiledChild validates the ODDITY platform, METHODIQ is an early proof point in medical-grade and longevity offerings, and Brand 4 is planned for 2027. On IL MAKIAGE, his tone was candid but determined: he said the issue is a technical algorithm problem with the ad partner, not brand damage, and that he is working on it daily.
Lindsay Mann focused on the quarter’s financial improvement and the company’s balance sheet. She said revenue decline improved from 25% in Q2 to 2% in Q3, aided by better repeat-order trends, while more than 80% of net revenue came from repeat sales. She highlighted gross margin pressure from lower AOV and first-order mix, adjusted EBITDA of $22 million, adjusted EPS of $0.37, free cash flow of $10 million, and $561 million of cash, cash equivalents, and investments, with $350 million of credit facilities undrawn. She also noted $163 million of share repurchases in the first nine months, reducing shares outstanding by about 20%, and said IL MAKIAGE inventory should be in better balance in 2027.
Analysts pressed on why Q3 outperformed, what that implies for Q4, and how the company is thinking about 2027. Management said Q3 was generally in line with plan, with SpoiledChild and METHODIQ outperforming expectations, while Q4 is being kept conservative to preserve flexibility as the company works to reset IL MAKIAGE’s ad algorithm. Questions also centered on peptides, ad partner dependence, gross margin, and whether IL MAKIAGE needs broader distribution; management said peptides are attractive but investment will be disciplined by payback and 12-month profitability, and IL MAKIAGE remains 100% D2C for now.
The call showed several signs of stabilization: revenue decline improved sharply sequentially, repeat orders held up, and adjusted EBITDA beat expectations. SpoiledChild and METHODIQ are both growing well, and management believes the product pipeline for 2027 is the most exciting yet, with new categories like peptides, longevity, and metabolic health potentially expanding the addressable market.
IL MAKIAGE is still the main drag, with management repeatedly citing a large advertising-partner algorithm dislocation, volatile CPA trends, and the need to keep investing before growth returns. Gross margin is under pressure from mix and lower first-order volumes, and inventory remains elevated at IL MAKIAGE even as the company expects to work through it over time. Management also acknowledged that 2027 growth will require meaningful investment and that near-term volatility is likely to continue while they fix the business.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 61.3%
- Shares Outstanding
- 57.00M
- Float Shares
- 34.92M
of shares held by institutions
159 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Baillie Gifford & Co | 7.34M | ▼ 398.47K |
| Morgan Stanley | 4.68M | ▼ 750.67K |
| Blackrock, Inc. | 2.59M | ▼ 911.05K |
| Janus Henderson Group Ltd. | 2.09M | ▼ 337.00K |
| Fmr LLC | 1.89M | ▲ 691.63K |
| Msd Partners, L.P. | 1.78M | 0 |
| D. E. Shaw & Co., Inc. | 1.44M | ▲ 178.90K |
| Frontier Capital Management Co LLC | 1.08M | ▼ 760.49K |
| Ubs Group AG | 1.01M | ▲ 335.74K |
| State Street Corp | 794.64K | ▼ 41.81K |
| Citigroup Inc | 764.50K | ▼ 151.90K |
| Jpmorgan Chase & Co | 526.53K | ▼ 111.76K |
Held by 135 ETFs
Biggest fund positions in ODD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 31, 26 | Drucker Mann Lindsay | other | 23,930 |
| Oct 31, 26 | Drucker Mann Lindsay | other | 23,930 |
| Nov 2, 26 | Drucker Mann Lindsay | other | 22,423 |
| Sep 30, 26 | Drucker Mann Lindsay | other | 23,929 |
| Sep 30, 26 | Drucker Mann Lindsay | other | 23,929 |
| Sep 30, 26 | Drucker Mann Lindsay | other | 12,216 |
| Sep 1, 26 | Drucker Mann Lindsay | other | 7,717 |
| Sep 3, 26 | Drucker Mann Lindsay | other | 809 |
| Sep 1, 26 | Drucker Mann Lindsay | other | 7,717 |
| Sep 3, 26 | Drucker Mann Lindsay | other | 809 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ODD coverage
Recent articles, reports, and earnings notes.
No research on ODD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ODD report →Oddity Tech: Recovery Visible, But Growth Isn't Guaranteed Yet
seekingalpha.com · Nov 12
These Analysts Boost Their Forecasts On Oddity Tech After Upbeat Q3 Results
benzinga.com · Nov 12
Oddity Tech (ODD) Q3 Earnings and Revenues Beat Estimates
zacks.com · Nov 11
Oddity Tech Ltd. (ODD) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 11
What ODDITY Tech (ODD) Said on Its Q3 Earnings Call
marketbeat.com · Nov 11
ODDITY Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue And Adjusted EBITDA Outlook
globenewswire.com · Nov 11
New Strong Buy Stocks for November 4th
zacks.com · Nov 4
New Strong Buy Stocks for October 29th
zacks.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.